• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞色素P450诱导剂孕烯醇酮-16α-腈对肝脏共价DNA修饰(I类化合物)的性别特异性调节作用。

Sex-specific modulation of hepatic covalent DNA modifications (I-compounds) by the cytochrome P450 inducer, pregnenolone-16 alpha-carbonitrile.

作者信息

Moorthy B, van Golen K L, Randerath K

机构信息

Department of Pharmacology, Baylor College of Medicine, Houston, Texas 77030.

出版信息

Toxicol Appl Pharmacol. 1992 Apr;113(2):218-26. doi: 10.1016/0041-008x(92)90117-b.

DOI:10.1016/0041-008x(92)90117-b
PMID:1561630
Abstract

I-compounds are recently discovered, age-dependent covalent DNA modifications, which are detectable by 32P-postlabeling assay for DNA adducts. The effects of the catatoxic antiglucocorticoid, pregnenolone-16 alpha-carbonitrile (PCN), on hepatic and renal I-compound levels have been studied in male and female Sprague-Dawley rats together with the levels of microsomal cytochrome P450 and rates of ethylmorphine N-demethylation. PCN (50 mg/kg ip) was dissolved in corn oil and administered to rats once daily for 4 days, and animals were killed at 1 day or 8 days after the last treatment. Hepatic and renal I-compounds were analyzed by 32P-postlabeling in control and PCN-treated animals at both time points. Microsomal cytochrome P450 and ethylmorphine N-demethylase activities were also determined. Total levels of liver nonpolar and polar I-compounds were reduced in female rats by 37 and 51%, respectively, compared to controls, at 1 day. Ten out of sixteen individual I-compounds were also markedly reduced in female rat liver DNA as a result of PCN administration. In contrast to females, total levels of liver I-compounds were not significantly altered in males by PCN at 1 day; however, two individual I-compounds were lowered. I-compound levels recovered 8 days after termination of PCN treatment in both males and females. Total levels of renal I-compounds were not affected by PCN treatment in either males or females. [3H]Methylthymidine incorporation studies showed an increase in mean DNA synthesis rate at 1 day in liver of both males and females, but this was significant in males only. Marked induction of hepatic microsomal cytochrome P450 (2.2-fold) and ethylmorphine N-demethylase (4.0-fold) activity was observed in female rats treated with PCN at 1 day as compared to controls. The extent of induction of these enzymes was much higher in females than males. At 8 days the levels of cytochrome P450 and ethylmorphine N-demethylase activity had returned to uninduced values. The results are consistent with a pivotal role for PCN-inducible cytochrome P450 in the metabolism of I-compounds.

摘要

I-化合物是最近发现的、与年龄相关的共价DNA修饰,可通过DNA加合物的32P后标记分析检测到。已在雄性和雌性Sprague-Dawley大鼠中研究了抗糖皮质激素孕烯醇酮-16α-腈(PCN)对肝脏和肾脏I-化合物水平的影响,同时研究了微粒体细胞色素P450水平和乙基吗啡N-去甲基化速率。将PCN(50mg/kg,腹腔注射)溶于玉米油中,每天给大鼠给药一次,共给药4天,在最后一次给药后1天或8天处死动物。在两个时间点对对照动物和PCN处理的动物的肝脏和肾脏I-化合物进行32P后标记分析。还测定了微粒体细胞色素P450和乙基吗啡N-脱甲基酶活性。与对照组相比,雌性大鼠肝脏中非极性和极性I-化合物的总水平在1天时分别降低了37%和51%。由于给予PCN,雌性大鼠肝脏DNA中16种单个I-化合物中的10种也显著降低。与雌性相反,PCN在1天时对雄性大鼠肝脏I-化合物的总水平没有显著影响;然而,有两种单个I-化合物水平降低。在PCN治疗终止8天后,雄性和雌性大鼠的I-化合物水平均恢复。PCN治疗对雄性或雌性大鼠肾脏I-化合物的总水平均无影响。[3H]甲基胸苷掺入研究表明,雄性和雌性大鼠肝脏在1天时平均DNA合成速率均增加,但仅在雄性中显著。与对照组相比,在1天时用PCN处理的雌性大鼠中观察到肝脏微粒体细胞色素P450(2.2倍)和乙基吗啡N-脱甲基酶(4.0倍)活性显著诱导。这些酶的诱导程度在雌性中比雄性高得多。在8天时,细胞色素P450水平和乙基吗啡N-脱甲基酶活性已恢复到未诱导值。结果表明PCN诱导的细胞色素P450在I-化合物代谢中起关键作用。

相似文献

1
Sex-specific modulation of hepatic covalent DNA modifications (I-compounds) by the cytochrome P450 inducer, pregnenolone-16 alpha-carbonitrile.细胞色素P450诱导剂孕烯醇酮-16α-腈对肝脏共价DNA修饰(I类化合物)的性别特异性调节作用。
Toxicol Appl Pharmacol. 1992 Apr;113(2):218-26. doi: 10.1016/0041-008x(92)90117-b.
2
Effects of cytochrome P450 inducers on I-compounds in rat liver and kidney DNA.细胞色素P450诱导剂对大鼠肝脏和肾脏DNA中I-化合物的影响。
Carcinogenesis. 1992 Jul;13(7):1191-8. doi: 10.1093/carcin/13.7.1191.
3
Effects of a single dose of the cytochrome P450 inducer, beta-naphthoflavone, on hepatic and renal covalent DNA modifications (I-compounds).单剂量细胞色素P450诱导剂β-萘黄酮对肝脏和肾脏共价DNA修饰(I型化合物)的影响。
Toxicology. 1995 Dec 15;104(1-3):165-77. doi: 10.1016/0300-483x(95)03181-e.
4
Ethylmorphine N-demethylase activity as a marker for cytochrome P450 CYP3A activity in rat hepatic microsomes.乙基吗啡N-脱甲基酶活性作为大鼠肝微粒体中细胞色素P450 CYP3A活性的标志物。
Toxicol Lett. 1998 Jan 31;94(2):115-25. doi: 10.1016/s0378-4274(97)00108-2.
5
Age- and sex-dependent induction of liver microsomal benzo[a]pyrene hydroxylase activity in rats treated with pregnenolone-16 alpha-carbonitrile (PCN).孕烯醇酮-16α-腈(PCN)处理的大鼠中肝微粒体苯并[a]芘羟化酶活性的年龄和性别依赖性诱导。
Carcinogenesis. 1985 Apr;6(4):617-24. doi: 10.1093/carcin/6.4.617.
6
The suppressive effect of the catatoxic steroid, pregnenolone-16alpha-carbonitrile, on liver microsomal cholesterol-7alpha-hydroxlyase.抗毒皮质类固醇孕烯醇酮-16α-腈对肝脏微粒体胆固醇-7α-羟化酶的抑制作用。
Steroids. 1978 Jun;31(6):849-54. doi: 10.1016/s0039-128x(78)80048-8.
7
Evidence for a PCN-P450 enzyme in chickens and comparison of its development with that of other phenobarbital-inducible forms.鸡体内一种PCN-P450酶的证据及其与其他苯巴比妥诱导型形式的发育比较。
Mol Pharmacol. 1989 May;35(5):610-6.
8
3-Methylcholanthrene-inducible liver cytochrome(s) P450 in female Sprague-Dawley rats: possible link between P450 turnover and formation of DNA adducts and I-compounds.3-甲基胆蒽诱导的雌性斯普拉格-道利大鼠肝脏细胞色素P450:P450周转与DNA加合物和I型化合物形成之间的可能联系
Carcinogenesis. 1993 May;14(5):879-86. doi: 10.1093/carcin/14.5.879.
9
Effects of pregnenolone-16 alpha-carbonitrile on drug metabolizing enzymes in hypophysectomized female rats.孕烯醇酮 -16α- 腈对垂体切除雌性大鼠药物代谢酶的影响。
Life Sci. 1987 Aug 31;41(9):1141-8. doi: 10.1016/0024-3205(87)90633-3.
10
Preparation and characterization of monoclonal antibodies to pregnenolone 16-alpha-carbonitrile inducible rat liver cytochrome P-450.孕烯醇酮16-α-腈诱导的大鼠肝脏细胞色素P-450单克隆抗体的制备与鉴定
Biochem Pharmacol. 1986 Sep 1;35(17):2859-67. doi: 10.1016/0006-2952(86)90477-6.